It is labeled as "1. Neurofilament light (NfL)", defined as: "2. A biomarker measured in plasma or cerebrospinal fluid that is associated with cognitive decline and neurodegeneration, particularly in Alzheimer disease and mild cognitive impairment, and is used as a prognostic marker for disease progression.", and related terms include "neurodegeneration marker".